Massimo Libra
Impact in
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 0.5%
- Cancer-related Molecular Pathways
Papers in
-
- Melanoma and MAPK Pathways 30
- PI3K/AKT/mTOR signaling in cancer 27
- Epigenetics and DNA Methylation 15
- Oncology 70
- Co-authors
- Luca Falzone (77 shared papers)James A. McCubrey (85 shared papers)Linda S. Steelman (54 shared papers)Alberto M. Martelli (49 shared papers)Saverio Candido (73 shared papers)Franca Stivala (38 shared papers)Stephen L. Abrams (36 shared papers)Jörg Bäsecke (19 shared papers)
- Journals
- Advances in Biological Regulation (15 papers)International Journal of Oncology (14 papers)Cell Cycle (13 papers)Oncotarget (12 papers)International Journal of Molecular Medicine (10 papers)
- Partner nations
- ItalyUnited StatesGreece
In The Last Decade
Massimo Libra
285 papers receiving 16.0k citations
Massimo Libra's Hit Papers
Peers
Comparison fields: 5 of 172
- Cancer Research 2.7k
- Oncology 3.7k
- Molecular Biology 7.7k
- Immunology 1.5k
- Hematology 770
Countries citing papers authored by Massimo Libra
This map shows the geographic impact of Massimo Libra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Libra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Libra more than expected).
Fields of papers citing papers by Massimo Libra
This network shows the impact of papers produced by Massimo Libra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Libra. The network helps show where Massimo Libra may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Libra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 291 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance Hit paper breakdown → | 2006 | 1865 |
| 2 | Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium Hit paper breakdown → | 2018 | 637 |
| 3 | Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance Hit paper breakdown → | 2006 | 551 |
| 4 | Cutaneous melanoma: From pathogenesis to therapy (Review) Hit paper breakdown → | 2018 | 437 |
| 5 | Gut Microbiota and Cancer: From Pathogenesis to Therapy Hit paper breakdown → | 2019 | 416 |
| 6 | 2014 | 407 | |
| 7 | 2008 | 303 | |
| 8 | 2015 | 299 | |
| 9 | 2013 | 223 | |
| 10 | 2011 | 205 | |
| 11 | 2020 | 203 | |
| 12 | 2008 | 189 | |
| 13 | 2019 | 186 | |
| 14 | 2019 | 175 | |
| 15 | 2012 | 166 | |
| 16 | 2011 | 165 | |
| 17 | 2019 | 164 | |
| 18 | 2009 | 164 | |
| 19 | 2018 | 160 | |
| 20 | 2020 | 160 |
About Massimo Libra
Massimo Libra is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Immunology, having authored 291 papers that have together received 16.2k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (30 papers), PI3K/AKT/mTOR signaling in cancer (27 papers), MicroRNA in disease regulation (22 papers), Cancer-related molecular mechanisms research (19 papers), Chronic Lymphocytic Leukemia Research (16 papers), Epigenetics and DNA Methylation (15 papers), Hepatitis C virus research (14 papers) and Lymphoma Diagnosis and Treatment (13 papers). The work is most often cited by research in Cancer Research (2.7k citations), Oncology (3.7k citations), Molecular Biology (7.7k citations), Immunology (1.5k citations) and Hematology (770 citations). Massimo Libra has collaborated with scholars based in Italy, United States and Greece. Frequent co-authors include Luca Falzone, James A. McCubrey, Linda S. Steelman, Alberto M. Martelli, Saverio Candido, Franca Stivala, Stephen L. Abrams, Jörg Bäsecke, Ferdinando Nicoletti and Demetrios�� Spandidos. Their work appears in journals such as Advances in Biological Regulation, International Journal of Oncology, Cell Cycle, Oncotarget and International Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.